Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled?
Identifieur interne : 000335 ( Main/Exploration ); précédent : 000334; suivant : 000336Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled?
Auteurs : Mohamed M. Nasrallah [Égypte] ; Noha A. Osman [Égypte] ; Mahmoud Elalfy [Égypte] ; Paolo Malvezzi [France] ; Lionel Rostaing [France]Source :
- Reviews in medical virology [ 1099-1654 ] ; 2020.
Abstract
Due to the Covid-19 pandemic caused by SARS-CoV-2, transplant programs worldwide have been severely impacted with dwindling numbers of transplantations performed and a complete halt in several areas. In this review we examine whether SARS-CoV-2 infection presents differently in transplant recipients, whom and how we should test, how susceptible the transplant population is to overt infection and describe the range of outcomes. From retrieved published reports on SARS-CoV-2infections in 389solid organ transplant recipients reported in the literature, the overall mortality rate was 16.7% (n = 65); however for those with mild or moderate Covid-19 disease this was 2.9% and 2.3% respectively; conversely, for those with severe infection the mortality rate was 52.2%.We then address questions regarding halting transplantation programs during this pandemic, whether all human tissues being considered for transplantation are capable of transmitting the infection, and if we should alter immunosuppressive medications during the pandemic.
DOI: 10.1002/rmv.2149
PubMed: 32954602
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled?</title><author><name sortKey="Nasrallah, Mohamed M" sort="Nasrallah, Mohamed M" uniqKey="Nasrallah M" first="Mohamed M" last="Nasrallah">Mohamed M. Nasrallah</name><affiliation wicri:level="1"><nlm:affiliation>Department of Nephrology, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Department of Nephrology, Kasr Al Ainy School of Medicine, Cairo University, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Misr International Hospital, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Misr International Hospital, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="Osman, Noha A" sort="Osman, Noha A" uniqKey="Osman N" first="Noha A" last="Osman">Noha A. Osman</name><affiliation wicri:level="1"><nlm:affiliation>Department of Nephrology, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Department of Nephrology, Kasr Al Ainy School of Medicine, Cairo University, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Misr International Hospital, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Misr International Hospital, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="Elalfy, Mahmoud" sort="Elalfy, Mahmoud" uniqKey="Elalfy M" first="Mahmoud" last="Elalfy">Mahmoud Elalfy</name><affiliation wicri:level="1"><nlm:affiliation>Misr International Hospital, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Misr International Hospital, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Cairo University Student's Hospital, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Cairo University Student's Hospital, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="Malvezzi, Paolo" sort="Malvezzi, Paolo" uniqKey="Malvezzi P" first="Paolo" last="Malvezzi">Paolo Malvezzi</name><affiliation wicri:level="3"><nlm:affiliation>Service de Néphrologie, Hémodialyse, Aphérèseset Transplantation Rénale, CHU Grenoble-Alpes, Grenoble, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Néphrologie, Hémodialyse, Aphérèseset Transplantation Rénale, CHU Grenoble-Alpes, Grenoble</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Grenoble</settlement></placeName></affiliation></author><author><name sortKey="Rostaing, Lionel" sort="Rostaing, Lionel" uniqKey="Rostaing L" first="Lionel" last="Rostaing">Lionel Rostaing</name><affiliation wicri:level="3"><nlm:affiliation>Service de Néphrologie, Hémodialyse, Aphérèseset Transplantation Rénale, CHU Grenoble-Alpes, Grenoble, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Néphrologie, Hémodialyse, Aphérèseset Transplantation Rénale, CHU Grenoble-Alpes, Grenoble</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Grenoble</settlement></placeName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Université Grenoble Alpes, Grenoble, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Grenoble Alpes, Grenoble</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Grenoble</settlement></placeName><orgName type="university">Université Grenoble-Alpes</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32954602</idno><idno type="pmid">32954602</idno><idno type="doi">10.1002/rmv.2149</idno><idno type="wicri:Area/Main/Corpus">000059</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000059</idno><idno type="wicri:Area/Main/Curation">000059</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000059</idno><idno type="wicri:Area/Main/Exploration">000059</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled?</title><author><name sortKey="Nasrallah, Mohamed M" sort="Nasrallah, Mohamed M" uniqKey="Nasrallah M" first="Mohamed M" last="Nasrallah">Mohamed M. Nasrallah</name><affiliation wicri:level="1"><nlm:affiliation>Department of Nephrology, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Department of Nephrology, Kasr Al Ainy School of Medicine, Cairo University, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Misr International Hospital, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Misr International Hospital, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="Osman, Noha A" sort="Osman, Noha A" uniqKey="Osman N" first="Noha A" last="Osman">Noha A. Osman</name><affiliation wicri:level="1"><nlm:affiliation>Department of Nephrology, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Department of Nephrology, Kasr Al Ainy School of Medicine, Cairo University, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Misr International Hospital, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Misr International Hospital, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="Elalfy, Mahmoud" sort="Elalfy, Mahmoud" uniqKey="Elalfy M" first="Mahmoud" last="Elalfy">Mahmoud Elalfy</name><affiliation wicri:level="1"><nlm:affiliation>Misr International Hospital, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Misr International Hospital, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Cairo University Student's Hospital, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Cairo University Student's Hospital, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="Malvezzi, Paolo" sort="Malvezzi, Paolo" uniqKey="Malvezzi P" first="Paolo" last="Malvezzi">Paolo Malvezzi</name><affiliation wicri:level="3"><nlm:affiliation>Service de Néphrologie, Hémodialyse, Aphérèseset Transplantation Rénale, CHU Grenoble-Alpes, Grenoble, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Néphrologie, Hémodialyse, Aphérèseset Transplantation Rénale, CHU Grenoble-Alpes, Grenoble</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Grenoble</settlement></placeName></affiliation></author><author><name sortKey="Rostaing, Lionel" sort="Rostaing, Lionel" uniqKey="Rostaing L" first="Lionel" last="Rostaing">Lionel Rostaing</name><affiliation wicri:level="3"><nlm:affiliation>Service de Néphrologie, Hémodialyse, Aphérèseset Transplantation Rénale, CHU Grenoble-Alpes, Grenoble, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Néphrologie, Hémodialyse, Aphérèseset Transplantation Rénale, CHU Grenoble-Alpes, Grenoble</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Grenoble</settlement></placeName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Université Grenoble Alpes, Grenoble, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Grenoble Alpes, Grenoble</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Grenoble</settlement></placeName><orgName type="university">Université Grenoble-Alpes</orgName></affiliation></author></analytic><series><title level="j">Reviews in medical virology</title><idno type="eISSN">1099-1654</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Due to the Covid-19 pandemic caused by SARS-CoV-2, transplant programs worldwide have been severely impacted with dwindling numbers of transplantations performed and a complete halt in several areas. In this review we examine whether SARS-CoV-2 infection presents differently in transplant recipients, whom and how we should test, how susceptible the transplant population is to overt infection and describe the range of outcomes. From retrieved published reports on SARS-CoV-2infections in 389solid organ transplant recipients reported in the literature, the overall mortality rate was 16.7% (n = 65); however for those with mild or moderate Covid-19 disease this was 2.9% and 2.3% respectively; conversely, for those with severe infection the mortality rate was 52.2%.We then address questions regarding halting transplantation programs during this pandemic, whether all human tissues being considered for transplantation are capable of transmitting the infection, and if we should alter immunosuppressive medications during the pandemic.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32954602</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1654</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Reviews in medical virology</Title><ISOAbbreviation>Rev. Med. Virol.</ISOAbbreviation></Journal><ArticleTitle>Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled?</ArticleTitle><Pagination><MedlinePgn>e2149</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/rmv.2149</ELocationID><Abstract><AbstractText>Due to the Covid-19 pandemic caused by SARS-CoV-2, transplant programs worldwide have been severely impacted with dwindling numbers of transplantations performed and a complete halt in several areas. In this review we examine whether SARS-CoV-2 infection presents differently in transplant recipients, whom and how we should test, how susceptible the transplant population is to overt infection and describe the range of outcomes. From retrieved published reports on SARS-CoV-2infections in 389solid organ transplant recipients reported in the literature, the overall mortality rate was 16.7% (n = 65); however for those with mild or moderate Covid-19 disease this was 2.9% and 2.3% respectively; conversely, for those with severe infection the mortality rate was 52.2%.We then address questions regarding halting transplantation programs during this pandemic, whether all human tissues being considered for transplantation are capable of transmitting the infection, and if we should alter immunosuppressive medications during the pandemic.</AbstractText><CopyrightInformation>© 2020 John Wiley & Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>NasrAllah</LastName><ForeName>Mohamed M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-5650-3000</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Misr International Hospital, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osman</LastName><ForeName>Noha A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Misr International Hospital, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elalfy</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Misr International Hospital, Cairo, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cairo University Student's Hospital, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malvezzi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service de Néphrologie, Hémodialyse, Aphérèseset Transplantation Rénale, CHU Grenoble-Alpes, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rostaing</LastName><ForeName>Lionel</ForeName><Initials>L</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-5130-7286</Identifier><AffiliationInfo><Affiliation>Service de Néphrologie, Hémodialyse, Aphérèseset Transplantation Rénale, CHU Grenoble-Alpes, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Grenoble Alpes, Grenoble, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Rev Med Virol</MedlineTA><NlmUniqueID>9112448</NlmUniqueID><ISSNLinking>1052-9276</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">immunosuppression</Keyword><Keyword MajorTopicYN="N">kidney transplantation</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">solid organ transplantation</Keyword><Keyword MajorTopicYN="N">waiting list</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>06</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>07</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>07</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32954602</ArticleId><ArticleId IdType="doi">10.1002/rmv.2149</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>The ERA-EDTA COVID-19 Database for Patients on Kidney Replacement Therapy https://www.era-edta.org/en/wp-content/uploads/2020/04/ERACODA-Study-Report-2020-04-29.pdf</Citation></Reference><Reference><Citation>Boyarsky BJ, Po-Yu Chiang T, Werbel WA, et al. Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant. 2020;20:1809-1818. https://doi.org/10.1111/ajt.15915.</Citation></Reference><Reference><Citation>Ahn C, Amer H, Anglicheau D, et al. Global transplantation COVID report march 2020. Transplantation. 2020. https://doi.org/10.1097/TP.0000000000003258. [Epub ahead of Print]</Citation></Reference><Reference><Citation>Ritschl PV, Nevermann N, Wiering L, et al. Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: a by-proxy society recommendation consensus approach. Am J Transplant. 2020;20:1826-1836. https://doi.org/10.1111/ajt.15933.</Citation></Reference><Reference><Citation>Angelico R, Trapani S, Manzia TM, Lombardini L, Tisone G, Cardillo M. The COVID-19 outbreak in Italy: initial implications for organ transplantation programs. Am J Transplant. 2020;20:1780-1784. https://doi.org/10.1111/ajt.15904.</Citation></Reference><Reference><Citation>Domínguez-Gil B, Coll E, Fernández-Ruiz M, et al. COVID-19 in Spain: Transplantation in the midst of the pandemic. Am J Transplant 2020;20(9):2593-2598. https://doi.org/10.1111/ajt.15983</Citation></Reference><Reference><Citation>Vetter P, Vu DL, L'Huillier AG, Schibler M, Kaiser L, Jacquerioz F. Clinical features of Covid-19. BMJ. 2020. https://doi.org/10.1136/bmj.m1470</Citation></Reference><Reference><Citation>Centre of Evidence Based Medicine, Oxford. Global Covid-19 Case Fatality Rates. https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/. Accessed May 15, 2020.</Citation></Reference><Reference><Citation>Rajgor DD, Lee MH, Archuleta S, Bagdasarian N, Quek SC. The many estimates of the COVID-19 case fatality rate. Lancet Infect Dis. 2020;20(7):776-777. https://doi.org/10.1016/S1473-3099(20)30244-9.</Citation></Reference><Reference><Citation>European Renal Association-European Dialysis and Transplantation Association. COVID-19: Information on Registry Initiatives. https://era-edta-reg.org/index.jsp?p=covid19</Citation></Reference><Reference><Citation>By the SIN Board, Regional Presidents, RIDT G. Quintaliani, A. di Napoli and C. Valletta data processing SIN CD: G. Brunori, F Aucella, P. Messa, M. Bosco,, F. Malberti, M. Mandreoli, S. Mazzaferro, E. Movilli, M. Ravera, M. Salomone, D. Santoro, G.Quintaliani SIN Secretariat: R. D'Arcangelo, C. Valletta, E. Coppari. Seconda Indagine SIN su Covid 19 e impatto su pazienti dializzati e trapiantati, centri dialisi ed operatori nefrologici. https://sinitaly.org/wp-content/uploads/2020/05/2-Survey-Covid-19-SIN-1.pdf. Accessed May 28, 2020.</Citation></Reference><Reference><Citation>Sánchez-Álvarez JE, Pérez Fontán M, Jiménez Martín C, et al. Situación de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo. Informe del Registro COVID-19 de la Sociedad Española de Nefrología (SEN). Nefrología. 2020;40(3):272-278. https://doi.org/10.1016/j.nefro.2020.04.002</Citation></Reference><Reference><Citation>Banerjee D, Popoola J, Shah S, Ster IC, Quan V, Phanish M. COVID-19 infection in kidney transplant recipients. Kidney Int. 2020;97(6):1076-1082. https://doi.org/10.1016/j.kint.2020.03.018</Citation></Reference><Reference><Citation>D'Antiga L. Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transpl. 2020;26:832-834. https://doi.org/10.1002/lt.25756.</Citation></Reference><Reference><Citation>Pormohammad A, Ghorbani S, Khatami A, et al. Comparison of confirmed COVID - 19 with SARS and MERS cases-clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. Rev Med Virol. 2020;e2112.</Citation></Reference><Reference><Citation>Fishman JA. The Immunocompromised transplant recipient and SARS-CoV-2 infection. J Am Soc Nephrol. 2020;31(6):1147-1149. https://doi.org/10.1681/ASN.2020040416</Citation></Reference><Reference><Citation>Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. https://doi.org/10.1056/NEJMoa2002032.</Citation></Reference><Reference><Citation>Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet. 2020;395(10223):507-513. https://doi.org/10.1016/S0140-6736(20)30211-7.</Citation></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5.</Citation></Reference><Reference><Citation>Pereira MR, Mohan S, Cohen DJ, et al. COVID-19 in solid organ transplant recipients: initial report from the US epicenter. Am J Transplant. 2020;20:1800-1808. https://doi.org/10.1111/ajt.15941.</Citation></Reference><Reference><Citation>Guillen E, Pineiro GJ, Revuelta I, et al. Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation? Am J Transplant. 2020;20:1875-1878. https://doi.org/10.1111/ajt.15874.</Citation></Reference><Reference><Citation>Ju C-R, Lian Q-Y, Zhang J-H, et al. Recommended prophylactic and management strategies for severe acute respiratory syndrome Coronavirus 2 infection in transplant recipients. Chronic Dis Transl Med. 2020;6(2):87-97. https://doi.org/10.1016/j.cdtm.2020.02.003</Citation></Reference><Reference><Citation>Hu L, Chen S, Fu Y, et al. Risk factors associated with clinical outcomes in 323 COVID-19 hospitalized patients in Wuhan, China. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa539.</Citation></Reference><Reference><Citation>Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region - Case series. N Engl J Med 2020 Mar 30. https://doi.org/10.1056/NEJMoa2004500, 382, 2012, 2022</Citation></Reference><Reference><Citation>Fang Y, Zhang H, Xie J, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020;Feb 19. https://doi.org/10.1148/radiol.2020200432.</Citation></Reference><Reference><Citation>López V, Vázquez T, Alonso-Titos J, et al. Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (Covid-19) en pacientes con trasplante renal. Nefrologia. 2020 Apr;40(3):265-271. https://doi.org/10.1016/j.nefro.2020.03.002.</Citation></Reference><Reference><Citation>Yan Y, Chang L, Wang L. Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019- nCoV): current status, challenges, and countermeasures. Rev Med Virol. 2020;30:e2106. https://doi.org/10.1002/rmv.2106.</Citation></Reference><Reference><Citation>Sethuraman N, Jeremiah SS, Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA. 2020;323:2249. https://doi.org/10.1001/jama.2020.8259.</Citation></Reference><Reference><Citation>Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843-1844. https://doi.org/10.1001/jama.2020.3786.</Citation></Reference><Reference><Citation>Theel ES, Slev P, Wheeler S, Couturier MR, Wong SJ, Kadkhoda K. The role of antibody testing for SARS-CoV-2: is there one? J Clin Microbiol 2020 Apr 29. https://doi.org/10.1128/JCM.00797-20</Citation></Reference><Reference><Citation>Jackson R. The GATE frame: critical appraisal with pictures. Evid Based Med. 2006;11(2):35-38. https://doi.org/10.1136/ebm.11.2.35. Accessed May25, 2020.</Citation></Reference><Reference><Citation>Agence de la Biomédecine. Situation de l'épidémie de Covid-19 chez les patients dialysés et greffés rénaux en France au 11 mai 2020.Bulletin N°7, 2020, May 11th. Accessed May 25, 2020.</Citation></Reference><Reference><Citation>Li Y, Yang N, Li X, Wang J, Yan T. Strategies for prevention and control of the 2019 novel coronavirus disease in the Department of Kidney Transplantation. Transpl Int. 2020;33(9):1040-1045. https://doi.org/10.1111/tri.13634</Citation></Reference><Reference><Citation>ISHLTConnect COVID-19 Community. https://community.ishlt.org/communities/community-home?communitykey=d3ab779b-4770-497a-af29474e493e3e6e&tab=groupdetails. Accessed May 28, 2020.</Citation></Reference><Reference><Citation>Yazici H. Beware of registries for their biases. Bull NYU Hosp Jt Dis. 2012;70(2):95-98.</Citation></Reference><Reference><Citation>ICNARC report on COVID-19 in critical care. https://www.icnarc.org/DataServices/Attachments/Download/c5a62b13-6486-ea11-9125-00505601089b. Accessed May 28, 2020.</Citation></Reference><Reference><Citation>Rokni M, Ghasemi V, Tavakoli Z. Immune responses and pathogenesis of SARS-CoV-2 duringan outbreak in Iran: comparison with SARS and MERS. Rev Med Virol. 2020;30:e2107. https://doi.org/10.1002/rmv.2107.</Citation></Reference><Reference><Citation>Ahmadapoor P, Rostaing L. Why the immune system fails to mount an adaptive immune response to a Covid −19 infection. Transplant Int. 2020;33(7):824-825. https://doi.org/10.1111/TRI.13611.</Citation></Reference><Reference><Citation>Halazun KJ, Rosenblatt R. Lest we forget. Am J Transplant. 2020 Mar 31;20:1785-1786. https://doi.org/10.1111/ajt.15888.</Citation></Reference><Reference><Citation>Woolley AE, Mehra MR. Dilemma of organ donation in transplantation and the COVID-19 pandemic. J Heart Lung Transplant 2020;39(5):410-411. https://doi.org/10.1016/j.healun.2020.03.017</Citation></Reference><Reference><Citation>Kumar D, Manuel O, Natori Y, et al. COVID-19: a global transplant perspective on successfully navigating a pandemic. Am J Transplant. 2020;20:1773-1779. https://doi.org/10.1111/ajt.15876.</Citation></Reference><Reference><Citation>Chen J-Y, Qiao K, Liu F, et al. Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis. Chin Med J. 2020;133(12):1390-1396. https://doi.org/10.1097/CM9.0000000000000839.</Citation></Reference><Reference><Citation>Chen C-Y, Chen SF, Hollander SA, et al. Donor heart selection during the COVID-19 pandemic: a case study. J Heart Lung Transplant. 2020;39(5):497-498. https://doi.org/10.1016/j.healun.2020.03.018.</Citation></Reference><Reference><Citation>Polak WG, Fondevila C, Karam V, et al. Impact of COVID-19 on liver transplantation in Europe: alert from an early survey of European liver and intestine transplantation association (ELITA) and European liver transplant registry (ELTR). European liver, intestine transplant association (ELITA). Transpl Int. 2020. https://doi.org/10.1111/tri.13680 [Epub ahead of Print]</Citation></Reference><Reference><Citation>Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ. End-stage liver disease patients withMELD >40 have higher waitlist mortality compared to status 1A patients. Hepatol Int. 2016;10(5):838-846. https://doi.org/10.1007/s12072-016-9735-4.</Citation></Reference><Reference><Citation>Travi G, Rossotti R, Merli M, et al. Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience. Am J Transplant. 2020;20(9):2628-2629. https://doi.org/10.1111/ajt.16069</Citation></Reference><Reference><Citation>Crespo M, Pérez-Sáez MJ, Redondo-Pachón D, et al. COVID-19 in elderly kidney transplant recipients. Am J Transplant, 2020. https://doi.org/10.1111/ajt.16096. [Epub ahead of print]</Citation></Reference><Reference><Citation>Loupy A, Aubert O, Reese PP, Bastien O, Bayer F, Jacquelinet C. Organ procurement and transplantation during the COVID-19 pandemic. Lancet. 2020;S0140-6736(20)31040-0. https://doi.org/10.1016/S0140-6736(20)31040-0.</Citation></Reference><Reference><Citation>Ravaioli M, Comai G, Germinario G, Maroni L, La Manna G. Kidney transplantation with pre-symptomatic COVID-19 positive surgeon. Am J Transplant. 2020;20(9):2624-2625. https://doi.org/10.1111/ajt.15971</Citation></Reference><Reference><Citation>Ho QY, Chung SJ, Gan VHL, Ng LG, Tan BH, Kee TYS. High-immunological risk living donor renal transplant during the COVID-19 outbreak: uncertainties and ethical dilemmas. Am J Transplant. 2020;20:1949-1951. https://doi.org/10.1111/ajt.15949.</Citation></Reference><Reference><Citation>Transplantation ASo. https://www.myast.org/sites/default/files/COVID19%20FAQ%20Tx%20Centers%2003.20.2020-FINAL.pdf.</Citation></Reference><Reference><Citation>Organization WH. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public.</Citation></Reference><Reference><Citation>Prevention CoDCa. https://www.cdc.gov/coronavirus/2019-ncov/prepare/prevention.html.</Citation></Reference><Reference><Citation>World Health Organization. Coronavirus Disease (COVID-19) Outbreak https://www.who.int/emergencies/diseases/novel-coronavirus-2019.</Citation></Reference><Reference><Citation>Fix OK, Serper M. Telemedicine and Telehepatology during the COVID-19 pandemic. Clin Liver Dis. 2020;15(5):187-190. https://doi.org/10.1002/cld.971.</Citation></Reference><Reference><Citation>Szmuda T, Syed MT, Singh A, Ali S, Özdemir C, Słoniewski P. YouTube as a source of patientinformation for coronavirus disease (COVID-19): a content-quality and audience engagement analysis. Rev Med Virol. 2020;e2132. https://doi.org/10.1002/rmv.2132.</Citation></Reference><Reference><Citation>American Society of Transplantation, COVID-19 information. https://www.myast.org/covid-19-information</Citation></Reference><Reference><Citation>Zhu L, Gong N, Liu B, et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China. Eur Urol. 2020;77(6):748-754. https://doi.org/10.1016/j.eururo.2020.03.039</Citation></Reference><Reference><Citation>Decker A, Welzel M, Laubner K, et al. Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation. Am J Transplant. 2020. https://doi.org/10.1111/ajt.16133. [Epub ahead of print].</Citation></Reference><Reference><Citation>Bösch F, Börner N, Kemmner S, et al. Attenuated early inflammatory response in solid organ recipients with COVID-19. Clin Transplant. 2020;e14027. https://doi.org/10.1111/ctr.14027.</Citation></Reference><Reference><Citation>Shah MB, Lynch RJ, El-Haddad H, Doby B, Brockmeier D, Goldberg DS. Utilization of deceased donors during a pandemic: an argument against using SARS-CoV-2 positive donors. Am J Transplant 2020;20(7):1795-1799. https://doi.org/10.1111/ajt.15969.</Citation></Reference><Reference><Citation>Kates OS, Fisher CE, Rakita RM, Reyes JD, Limaye AP. Use of SARS-CoV-2 infected deceasedorgan donors: Should we always “just say no?” Am J Transplant. 2020;20(7):1787-1794. https://doi.org/10.1111/ajt.16000</Citation></Reference><Reference><Citation>Cho HJ, Koo JW, Roh SK, et al. COVID-19 transmission and blood transfusion: A case report. J Infect Public Health. 2020. https://doi.org/10.1016/j.jiph.2020.05.001. [Epub ahead of Print]</Citation></Reference><Reference><Citation>Hong HL, Kim SH, Choi DL, Kwon HH. A case of coronavirus disease 2019-infected liver transplant donor. Am J Transplant. 2020;https://doi.org/10.1111/ajt.15997. [Epub ahead of print]</Citation></Reference><Reference><Citation>Marx D, Moulin B, Fafi-Kremer S, et al. First case of COVID-19 in a kidney transplant recipient treated with belatacept. Am J Transplant 2020;20(7):1944-1946. https://doi.org/10.1111/ajt.15919.</Citation></Reference><Reference><Citation>Meziyerh S, Zwart TC, Etten RW, et al. Severe COVID-19 in a renal transplant recipient: a focus on pharmacokinetics. Am J Transplant 2020;20(7):1896-1901. https://doi.org/10.1111/ajt.15943.</Citation></Reference><Reference><Citation>Horby P, Lim WS, Jonathan E, et al; RECOVERY Collaborative Group. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report. medRxiv. 2020.20137273; https://doi.org/10.1101/2020.06.22.20137273</Citation></Reference><Reference><Citation>Rodriguez-Cubillo B, Moreno de la Higuera MA, Lucena R, et al. Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2? Am J Transplant. 2020. https://doi.org/10.1111/ajt.16141. [Epub ahead of print].</Citation></Reference><Reference><Citation>Ma-Lauer Y, Zhyen Y, Malešević M, von Brunn B, Fischer G, von Brunn A. Influences of cyclosporin a and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication. Antiviral Res. 2020;173:104620. https://doi.org/10.1016/j.antiviral.2019.104620.</Citation></Reference><Reference><Citation>Carbajo-Lozoya J, Ma M, Kallies S, et al. Replication of human coronaviruses SARS-COV, HCOV-NL63 AND HCOV-229e is inhibited by the drug FK506. Virus Res. 2012;165(1):112-117.</Citation></Reference><Reference><Citation>Shen L, Niu J, Wang C, et al. High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses. J Virol. 2019;93(12):e00023-19. https://doi.org/10.1128/JVI.00023-19.</Citation></Reference><Reference><Citation>Russell B, Moss C, George G, et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. E cancer medical science. 2020;14:1022. https://doi.org/10.3332/ecancer.2020.1022.</Citation></Reference><Reference><Citation>Wang J, Li X, Cao G, Wu X, Wang Z, Yan T. COVID-19 in a Kidney Transplant Patient. Eur Urol. 2020;S0302-2838(20):30211-6. https://doi.org/10.1016/j.eururo.2020.03.036</Citation></Reference><Reference><Citation>NasrAllah MM, Elalfy MM, Fakhry SA, et al. Impact of adopting routine Luminex-based Pretransplant assessment of HLA antibodies on clinical practice and outcomes in kidney transplantation. Transplant Proc. 2019;51(7):2241-2244. https://doi.org/10.1016/j.transproceed.2019.01.147</Citation></Reference><Reference><Citation>Gandolfini I, Delsante M, Fiaccadori E, et al. COVID-19 in kidney transplant recipients. Am J Transplant. 2020;20:1941-1943. https://doi.org/10.1111/ajt.15891.</Citation></Reference><Reference><Citation>Zhu L, Xu X, Ma K, et al. Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant. 2020;20:1859-1863. https://doi.org/10.1111/ajt.15869.</Citation></Reference><Reference><Citation>Huang J, Lin H, Wu Y, et al. COVID-19 in posttransplant patients-report of 2 cases. Am J Transplant. 2020;20(7):1879-1881. https://doi.org/10.1111/ajt.15896.</Citation></Reference><Reference><Citation>Liu B, Wang Y, Zhao Y, Shi H, Zeng F, Chen Z. Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient. Am J Transplant. 2020;20:1891-1895. https://doi.org/10.1111/ajt.15901.</Citation></Reference><Reference><Citation>Aslam S, Mehra MR. COVID-19: yet another coronavirus challenge in transplantation. J Heart Lung Transplant. 2020;39(5):408-409. https://doi.org/10.1016/j.healun.2020.03.007.</Citation></Reference><Reference><Citation>Zhang H, Chen Y, Yuan Q, et al. Identification of kidney transplant recipients with coronavirus disease 2019. Eur Urol. 2020;77(6):742-747. https://doi.org/10.1016/j.eururo.2020.03.030.</Citation></Reference><Reference><Citation>Aigner C, Dittmer U, Kamler M, Collaud S, Taube C. COVID-19 in a lung transplant recipient. J Heart Lung Transplant. 2020;S1053-2498(20)31511-4 https://doi.org/10.1016/j.healun.2020.04.004</Citation></Reference><Reference><Citation>Akalin E, Azzi Y, Bartash R, et al. Covid-19 and kidney transplantation. N Engl J Med. 2020;382:2475-2477. https://doi.org/10.1056/NEJMc2011117.</Citation></Reference><Reference><Citation>Hsu JJ, Gaynor P, Kamath M, et al. COVID-19 in a high-risk dual heart and kidney transplant recipient. Am J Transplant. 2020;20:1911-1915. https://doi.org/10.1111/ajt.15936.</Citation></Reference><Reference><Citation>Fernández-Ruiz M, Andrés A, Loinaz C, et al. COVID-19 in solid organ transplant recipients: a single-center case series from Spain. Am J Transplant. 2020;20:1849-1858. https://doi.org/10.1111/ajt.15929.</Citation></Reference><Reference><Citation>Kates OS, Fisher CE, Stankiewicz-Karita HC, et al. Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States. Am J Transplant. 2020;20:1885-1890. https://doi.org/10.1111/ajt.15944.</Citation></Reference><Reference><Citation>Arpali E, Akyollu B, Yelken B, Tekin S, Turkmen A, Kocak B. Case report: a kidney transplant patient with mild COVID-19. Transpl Infect Dis. 2020;22(4):e13296. https://doi.org/10.1111/tid.13296.</Citation></Reference><Reference><Citation>Zhong Z, Zhang Q, Xia H, et al. Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients. Am J Transplant. 2020;20:1916-1921. https://doi.org/10.1111/ajt.15928.</Citation></Reference><Reference><Citation>Kim Y, Kwon O, Paek JH, et al. Two distinct cases with COVID-19 in kidney transplant recipients. Am J Transplant. 2020;20(8):2269-2275. https://doi.org/10.1111/ajt.15947.</Citation></Reference><Reference><Citation>Seminari E, Colaneri M, Sambo M, et al. SARS Cov-2 infection in a renal-transplanted patient: a case report. Am J Transplant. 2020;20:1882-1884. https://doi.org/10.1111/ajt.15902.</Citation></Reference><Reference><Citation>Li F, Cai J, Dong N. First cases of COVID-19 in heart transplantation from China. J Heart Lung Transplant. 2020;39(5):496-497. https://doi.org/10.1016/j.healun.2020.03.006.</Citation></Reference><Reference><Citation>Trujillo H, Caravaca-Fontán F, Sevillano Á, et al. SARS-CoV-2 infection in hospitalized patients with kidney disease. Kidney Int Rep. 2020;5:905-909. https://doi.org/10.1016/j.ekir.2020.04.024.</Citation></Reference><Reference><Citation>Montagud-Marrahi E, Cofan F, Torregrosa J, et al. Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single Centre cohort of kidney recipients. Am J Transplant. 2020. https://doi.org/10.1111/ajt.15970. [Epub ahead of print].</Citation></Reference><Reference><Citation>Nair V, Jandovitz N, Hirsch JS, et al. COVID-19 in kidney transplant recipients. Am J Transplant. 2020;20:1819-1825. https://doi.org/10.1111/ajt.15967.</Citation></Reference><Reference><Citation>Alberici F, Delbarba E, Manenti C, et al. Management of Patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep. 2020;5(5):580-585. https://doi.org/10.1016/j.ekir.2020.04.001.</Citation></Reference><Reference><Citation>Mathies D, Rauschning D, Wagner U, et al. A case of SARS-CoV-2-pneumonia with successful antiviral therapy in a 77-year-old male with heart transplant. Am J Transplant. 2020;20:1925-1929. https://doi.org/10.1111/ajt.15932.</Citation></Reference><Reference><Citation>Mehta SA, Leonard J, Labella P, et al. Outpatient Management of Kidney Transplant Recipients with suspected COVID-19- single center experience during the new York City surge. Transpl Infect Dis. 2020;e13383. https://doi.org/10.1111/tid.13383. [Epub ahead of print].</Citation></Reference><Reference><Citation>Kolonko A, Dudzicz S, Wiecek A, Król R. COVID-19 infection in solid organ transplant recipients: a single center experience with patients immediately after transplantation. Transpl Infect Dis. 2020;e13381. https://doi.org/10.1111/tid.13381. [Epub ahead of print].</Citation></Reference><Reference><Citation>Chen TY, Farghaly S, Cham S, et al. COVID-19 pneumonia in kidney transplant recipients: focus on immunosuppression management. Transpl Infect Dis. 2020;e13378. https://doi.org/10.1111/tid.13378. [Epub ahead of print].</Citation></Reference><Reference><Citation>Marcault C, Fodil S, Dupont T, Darmon M, Azoulay E. Solid organ transplant recipients during COVID-19 pandemic. Am J Transplant. 2020. https://doi.org/10.1111/ajt.16126. [Epub ahead of print].</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li><li>Égypte</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Rhône-Alpes</li></region><settlement><li>Grenoble</li></settlement><orgName><li>Université Grenoble-Alpes</li></orgName></list><tree><country name="Égypte"><noRegion><name sortKey="Nasrallah, Mohamed M" sort="Nasrallah, Mohamed M" uniqKey="Nasrallah M" first="Mohamed M" last="Nasrallah">Mohamed M. Nasrallah</name></noRegion><name sortKey="Elalfy, Mahmoud" sort="Elalfy, Mahmoud" uniqKey="Elalfy M" first="Mahmoud" last="Elalfy">Mahmoud Elalfy</name><name sortKey="Elalfy, Mahmoud" sort="Elalfy, Mahmoud" uniqKey="Elalfy M" first="Mahmoud" last="Elalfy">Mahmoud Elalfy</name><name sortKey="Nasrallah, Mohamed M" sort="Nasrallah, Mohamed M" uniqKey="Nasrallah M" first="Mohamed M" last="Nasrallah">Mohamed M. Nasrallah</name><name sortKey="Osman, Noha A" sort="Osman, Noha A" uniqKey="Osman N" first="Noha A" last="Osman">Noha A. Osman</name><name sortKey="Osman, Noha A" sort="Osman, Noha A" uniqKey="Osman N" first="Noha A" last="Osman">Noha A. Osman</name></country><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Malvezzi, Paolo" sort="Malvezzi, Paolo" uniqKey="Malvezzi P" first="Paolo" last="Malvezzi">Paolo Malvezzi</name></region><name sortKey="Rostaing, Lionel" sort="Rostaing, Lionel" uniqKey="Rostaing L" first="Lionel" last="Rostaing">Lionel Rostaing</name><name sortKey="Rostaing, Lionel" sort="Rostaing, Lionel" uniqKey="Rostaing L" first="Lionel" last="Rostaing">Lionel Rostaing</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000335 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000335 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32954602
|texte= Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32954602" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |